HRB 2024 Evidence review on Drug and alcohol services

HRB 2024 Evidence review on the distribution, organisation and administration of drug and alcohol services in other European jurisdictions The Health Research Board (HRB) is a research organisation. One of its areas of expertise is alcohol and other drugs, and it holds two national information systems on the topic: the …

CPV: 79315000 Servicios de investigación social, 73110000 Servicios de investigación, 73210000 Servicios de consultoría en investigación
Plazo:
13 de noviembre de 2024 a las 10:00
Tipo de plazo:
Presentación de una oferta
Lugar de ejecución:
HRB 2024 Evidence review on Drug and alcohol services
Organismo adjudicador:
The Health Research Board
Número de premio:
0

1. Buyer

1.1 Buyer

Official name : The Health Research Board
Legal type of the buyer : Body governed by public law
Activity of the contracting authority : Health

1.1 Buyer

Official name : The Health Research Board
Legal type of the buyer : Body governed by public law
Activity of the contracting authority : Health

2. Procedure

2.1 Procedure

Title : HRB 2024 Evidence review on Drug and alcohol services
Description : HRB 2024 Evidence review on the distribution, organisation and administration of drug and alcohol services in other European jurisdictions The Health Research Board (HRB) is a research organisation. One of its areas of expertise is alcohol and other drugs, and it holds two national information systems on the topic: the National Drug Related Deaths Index and the National Drug Treatment Reporting System. It also hosts the National Drugs Library, which is an information resource that supports researchers, policy makers, educators, and practitioners who are working to develop the knowledge base around drug, alcohol, and tobacco use in Ireland. The HRB has commissioned nine evidence reviews since 2014 as part of the HRB drug and alcohol evidence review series (see Appendix 1). These reviews are undertaken on behalf of the Drugs Policy Unit in the Department of Health and funding is allocated each year in the national drugs strategy research and monitoring budget for this purpose. These evidence reviews support stakeholders in using research-based knowledge in their decision making, especially regarding their assigned actions under the National Drugs Strategy.
Procedure identifier : 25fcca44-fb43-48e0-8b79-322b4f515cbb
Type of procedure : Open
The procedure is accelerated : no
Justification for the accelerated procedure :
Main features of the procedure :

2.1.1 Purpose

Main nature of the contract : Services
Main classification ( cpv ): 79315000 Social research services
Additional classification ( cpv ): 73110000 Research services
Additional classification ( cpv ): 73210000 Research consultancy services

2.1.2 Place of performance

Country subdivision (NUTS) : Dublin ( IE061 )
Country : Ireland

2.1.3 Value

Estimated value excluding VAT : 70 000 Euro

2.1.4 General information

Legal basis :
Directive 2014/24/EU

2.1.5 Terms of procurement

Terms of submission :
Maximum number of lots for which one tenderer can submit tenders : 0

2.1.6 Grounds for exclusion

Purely national exclusion grounds :

5. Lot

5.1 Lot technical ID : LOT-0001

Title : HRB 2024 Evidence review on Drug and alcohol services
Description : HRB 2024 Evidence review on the distribution, organisation and administration of drug and alcohol services in other European jurisdictions The Health Research Board (HRB) is a research organisation. One of its areas of expertise is alcohol and other drugs, and it holds two national information systems on the topic: the National Drug Related Deaths Index and the National Drug Treatment Reporting System. It also hosts the National Drugs Library, which is an information resource that supports researchers, policy makers, educators, and practitioners who are working to develop the knowledge base around drug, alcohol, and tobacco use in Ireland. The HRB has commissioned nine evidence reviews since 2014 as part of the HRB drug and alcohol evidence review series (see Appendix 1). These reviews are undertaken on behalf of the Drugs Policy Unit in the Department of Health and funding is allocated each year in the national drugs strategy research and monitoring budget for this purpose. These evidence reviews support stakeholders in using research-based knowledge in their decision making, especially regarding their assigned actions under the National Drugs Strategy.
Internal identifier : 0

5.1.1 Purpose

Main nature of the contract : Services
Main classification ( cpv ): 79315000 Social research services
Additional classification ( cpv ): 73110000 Research services
Additional classification ( cpv ): 73210000 Research consultancy services

5.1.2 Place of performance

Country subdivision (NUTS) : Dublin ( IE061 )
Country : Ireland
Additional information :

5.1.3 Estimated duration

Other duration : Unknown

5.1.5 Value

Estimated value excluding VAT : 70 000 Euro

5.1.6 General information

Reserved participation : Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA) : yes

5.1.7 Strategic procurement

Aim of strategic procurement : No strategic procurement

5.1.9 Selection criteria

Criterion :
Type : Economic and financial standing

5.1.11 Procurement documents

Languages in which the procurement documents are officially available : English
Languages in which the procurement documents (or their parts) are unofficially available : English

5.1.12 Terms of procurement

Terms of submission :
Electronic submission : Required
Languages in which tenders or requests to participate may be submitted : English
Electronic catalogue : Not allowed
Tenderers may submit more than one tender : Not allowed
Deadline for receipt of tenders : 13/11/2024 10:00 +01:00
Information about public opening :
Opening date : 13/11/2024 10:30 +01:00
Terms of contract :
The execution of the contract must be performed within the framework of sheltered employment programmes : No
Electronic invoicing : Allowed
Electronic ordering will be used : yes
Electronic payment will be used : yes

5.1.15 Techniques

Framework agreement :
No framework agreement
Information about the dynamic purchasing system :
No dynamic purchase system
Electronic auction : no

5.1.16 Further information, mediation and review

Review organisation : The High Court of Ireland
Organisation providing offline access to the procurement documents : The Health Research Board
Organisation receiving requests to participate : The Health Research Board
Organisation processing tenders : The Health Research Board
TED eSender : European Dynamics S.A.

8. Organisations

8.1 ORG-0001

Official name : The Health Research Board
Registration number : 04820764P
Postal address : 67-72 Lower Mount Street,
Town : Dublin
Postcode : DO2 H638
Country : Ireland
Telephone : 012345000
Internet address : https://www.hrb.ie/
Buyer profile : https://www.hrb.ie/ https://www.hrb.ie
Roles of this organisation :
Buyer
Organisation providing offline access to the procurement documents
Organisation receiving requests to participate
Organisation processing tenders

8.1 ORG-0002

Official name : The High Court of Ireland
Registration number : The High Court of Ireland
Department : The High Court of Ireland
Postal address : Four Courts, Inns Quay, Dublin 7
Town : Dublin
Postcode : D07 WDX8
Country : Ireland
Telephone : +353 1 8886000
Roles of this organisation :
Review organisation

8.1 ORG-0003

Official name : European Dynamics S.A.
Registration number : 002024901000
Department : European Dynamics S.A.
Town : Athens
Country : Greece
Telephone : +30 2108094500
Roles of this organisation :
TED eSender

11. Notice information

11.1 Notice information

Notice identifier/version : 6a0fab1c-f8ed-47fc-bf51-8b1de8f21c72 - 01
Form type : Competition
Notice type : Contract or concession notice – standard regime
Notice dispatch date : 21/10/2024 12:54 +01:00
Languages in which this notice is officially available : English

11.2 Publication information

Notice publication number : 00639908-2024
OJ S issue number : 206/2024
Publication date : 22/10/2024